• Most Popular
  • Most Shared

MedImmune's FluMist benefits some young kids-panel

Wed May 16, 2007 1:31pm EDT

GAITHERSBURG, Md., May 16 (Reuters) - The benefits of MedImmune Inc.'s MEDI.O FluMist influenza vaccine outweigh any possible risks for some younger children, a U.S. advisory panel said on Wednesday.

Regulatory News

The Food and Drug Administration's panel of outside experts, in a 9-6 vote, found the nasal spray was beneficial for 1- to 5-year-olds. But the panel saw less benefit in children as young as 6 months old.

MedImmune is seeking wider approval for the vaccine, which is already approved for 5- to 49-year-olds.

Regulatory News


More from Reuters

Photo

Wide use of U.S. airport body scanners depends on Obama

NEW YORK (Reuters) - The path toward rolling out wider use of whole-body security scanners in U.S. airports runs through the White House.

» More Top News
EDITORS' NOTE: Reuters and other foreign media are subject to Iranian restrictions on leaving the office to report, film or take pictures in Tehran. A man holds a picture of Ayatollah Ruhollah Khomeini, founder of the Islamic Republic as government supporters protest against opposition demonstrations during the holy day of Ashura, in Tehran December, 30 2009. REUTERS/Caren Firouz

What next?

Six months after a disputed election, tension in Iran shows no signs of letting up.  Full Article 

IRAN
Disgraced financier Bernard Madoff is escorted by police and photographed by the media as he departs U.S. Federal Court after a hearing in New York, January 5, 2009. REUTERS/Lucas Jackson

I beg your pardon ...

Bernie Madoff became the poster boy of crooked investment schemes this year -- but he wasn't alone. Here's a look at the 10 most notorious cases of 2009.  Full Article 

Corporate Crime